Selank is a synthetic heptapeptide derived from a tuftsin-related sequence and investigated in laboratory models involving neurotransmitter-associated signaling, immune-neural communication, and gene-expression response. Proposed GABAergic and neurotrophic associations remain dependent on the experimental model.

Representative product imagery. Verify the physical label and lot documentation on receipt.
Selank
Selank peptide supplied in a 10 mg research vial. Each unit is labeled with a traceable lot code and links to its corresponding analytical report.
What researchers study
Selank is a synthetic peptide sequence used in laboratory neuro-signaling and analytical peptide research.
Neuro-signaling research investigates receptors, cellular communication, peptide stability, and analytical behavior in qualified in-vitro and biochemical models.
In-vitro neuro-signaling observations cannot be translated into cognitive, behavioral, psychiatric, or therapeutic claims. Appropriate controls and independent replication remain essential.
Sequence verification uses accurate intact mass, fragmentation ions, retention behavior, and qualified reference comparisons. This work confirms chemical identity without supporting cognitive, anxiolytic, psychiatric, or therapeutic claims.
Degradation studies monitor cleavage products, oxidation, deamidation, and adsorption in defined matrices. Sampling design should distinguish true chemical loss from container binding or inadequate analytical recovery.
Know what your laboratory receives.
Batch records are published for transparency and should be independently reviewed by qualified research personnel.
- Tamper-evident packaging
- Lot and SKU traceability
- Independent analytical review


